Abnormal drug accumulation in multidrug resistant gastric carcinoma cells

World Chinese Journal of Digestology

Volumn 9, Issue 2, 2001, Pages 131-134

  Shi Dan Cheng, ^a   Yun Lin Wu, ^a   Yong Ping Zhang, ^a   Min Min Qiao, ^a   Qiang Su Guo, ^a  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

Accumulation of drug; Antineoplastic agents; Daunorubicin; Multidrug resistance; Stomach neoplasms; Vincristine

Indexed keywords

DAUNORUBICIN; VINCRISTINE;

ARTICLE; CARCINOMA CELL; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONFOCAL LASER MICROSCOPY; DRUG ACCUMULATION; DRUG CYTOTOXICITY; DRUG UPTAKE; FLUORESCENCE; LIQUID SCINTILLATION COUNTING; MULTIDRUG RESISTANCE; STOMACH CARCINOMA;

EID: 0035117333     PISSN: 10093079     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Statistic of morbidity of malignant tumor of citizen in Shanghai in 1992
2. Expression of multidrug resistance-associated protein in gastric cancer and its prognostic significance
3. MDR1 gene expression and its clinical relevance in primary gastric carcinomas
4. 1mRNA expression in gastric and large intestinal cancers (Static analysis on 47 cases with computerized logistic regression)
5. Study of the Mdr1 gene product (PGP) expression in gastric carcinoma and chronic gastritis
6. Development of daunorubicin resistance in tumour cells by induction of carbonyl reduction
7. Flow cytometric evaluation of fas expression in relation to response and resistance to anthracyclines in leukemic cells
8. Molecular mechanisms of drug resistance
9. Clinical significance of P - Glycoprotein in multidrug resistance malignancies
10. Genetic analysis of the multidrug transporter
11. Studies on clinical relationship between multidrug resistance gene and digestive system neoplasms
12. Biological characterization of multidrug-resistant human colon carcinoma sublines induced/ selected by two methods
13. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line
14. Expression of multidrug resistance-associated protein (MRP) and multidrug resistance (MDR1) genes in acute myeloid leukemia
15. Chemoprotection of hematopoietic cells by a mutant P-glycoprotein resistant to a potent chemosensitizer of multidrug-resistant cancers
16. Increased expression of lung resistance-related protein and multidrug resistance-associated protein messenger RNA in childhood acute lymphoblastic leukemia
17. Expression of mdr-1 gene in human gastric carcinoma assayed by RT-PCR
18. Multidrug resistance-associated protein expression in clinical gastric carcinoma
19. Expression and significance of multidrug gene product P170 in gastric carcinoma
20. Expression significance of mdr1 gene in gastric carcinoma tissue
21. Establishment of adriamycine-resistant human ovarian carcinoma cell line and its mechanism of multidrug resistance
22. Establishment of multidrug-resistant cell lines K562/HHT and K562/VCR and reversal of drug-resistance
23. Drug transport mechanisms in HL60 cells isolated for resistance to adriamycin: Evidence for nuclear drag accumulation and redistribution in resistant cells
24. Expression of multidrug resistance-associated protein in NIH/3T3 cells confers multidrug resistance associated with increased drug efflux and altered intracellular drug distribution
25. Intracellular accumulation retention, and distribution of anthracyclines in a multidrug-resistant variant K562r
26. Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: Consensus recommendations
27. Kinetics of anthracycline efflux from multidrug resistance protein-expressing cancer cells compared with p-glycoprotein-expressing cancer cells
28. Functional multidrug resistance in acute myeloblastic leukaemia: A standardized flow cytometric assay for intracellular daunorubicin accumulation
29. Multidrug resistance (mdr) genes in human cancer
30. Biochemistry of multidrug resistance mediated by the multidrug transporter
31. Novel mechanisms of drug resistance in leukemia
32. Expression of the multidrug resistance-associated protein (MRP) gene correlates with amplification and overexpression of the N-myc oncogene in childhood neuroblastoma
33. Doxorubicin resistance in human melanoma cells: MDR-1 and glutathione S-transferase π gene expression
34. Clinical significance of determination of multidrug resistant gene expression by flow cytometry in malignant solid-tumors
35. Increased MRP expression is associated with resistance to radiation, anthracyclines and etoposide in cells treated with fractionated γ-radiation
36. Drug resistance factors in acute myeloid leukemia: A comparative analysis
37. Multidrug resistance protein 1 protects the choroid plexus epithelium and contributes to the blood-cerebrospinal fluid barrier
38. The influence of expression of P-glycoprotein on the penetration of anticancer drugs through multicellular layers
39. P-glycoprotein-overexpressing multidrug-resistant cells are resistant to infection by enveloped viruses that enter via the plasma membrane
40. P-glycoprotein (PGP), lung resistance-related protein (LRP) and multidrug resistance-associated protein (MRP) expression in acute promyelocytic leukaemia
41. Function and expression of multidrug resistance-associated protein family in human colon adenocarcinoma cells (Caco-2)
42. The relative importance of passive and P-glycoprotein mediated anthracycline efflux from multidrug-resistant cells
43. P-glycoprotein plays a drug-efflux-independent role in augmenting cell survival in acute myeloblastic leukemia and is associated with modulation of a sphingomyelin-ceramide apoptotic pathway
44. Low-level doxorubicin resistance in benzo[a]pyrene- treated KB-3-1 cells is associated with increased LRP expression and altered subcellular drug distribution
45. Reversal of acquired resistance to doxorubicin in K562 human leukemia cells by astemizole
46. Antisense inhibition of P-glycoprotein expression using peptide-oligonucleotide conjugates
47. Functional detection of MDR1/P170 and MRP/P190-mediated multidrug resistance in tumour cells by flow cytometry
48. The detection of rhodamine 123 efflux at low levels of drug resistance
49. Use of standardized flow cytometric determinants of multidrug resistance to analyse response to remission induction chemotherapy in patents with acute myeloblastic leukaemia
50. Molecular co-localization analysis with the software of laser scanning confocal microscope in digestology